NASDAQ : INCR
InterCure Ltd. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 3.97 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 51.59M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Details
| Name | InterCure Ltd. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 285 |
| Founded | 1994 |
| Ceo | Alexander Rabinovich |
| Country | Israel |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| Ipo Price | 0.00 |
| Isin | IL0011063760 |
| Cik | 1857030 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Einat Zehavi | Chief Executive Officer of Retail |
| Alexander Rabinovich | Founder, Chief Executive Officer and Chairman |
| Amos Cohen | Chief Financial Officer |
| Omer Layani | Chief Technology Officer |
| Yarin Lidor | Head of Marketing |
| Dean Simhon | Head of Supply Chain |
Contact
| Address | 85 Medinat ha-Yehudim Street, Herzliya, 4676670, Israel |
| Phone | 972 7 746 05012 |
| Website | https://www.intercure.co |